The DOI matches its Crossref record; 164 of the 164 references it cites were found in a registry or an index.
Glioma: experimental models and reality
Open accessAbstract
In theory, in vitro and in vivo models for human gliomas have great potential to not only enhance our understanding of glioma biology, but also to facilitate the development of novel treatment strategies for these tumors. For reliable prediction and validation of the effects of different therapeutic modalities, however, glioma models need to comply with specific and more strict demands than other models of cancer, and these demands are directly related to the combination of genetic aberrations and the specific brain micro-environment gliomas grow in. This review starts with a brief introduction on the pathological and molecular characteristics of gliomas, followed by an overview of the models that have been used in the last decades in glioma research. Next, we will discuss how these models may play a role in better understanding glioma development and especially in how they can aid in the design and optimization of novel therapies. The strengths and weaknesses of the different models will be discussed in light of genotypic, phenotypic and metabolic characteristics of human gliomas. The last part of this review provides some examples of how therapy experiments using glioma models can lead to deceptive results when such characteristics are not properly taken into account.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,657
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., Taphoorn, M. J., Janzer, R. C., Ludwin, S. K., Allgeier, A., Fisher, B., Belanger, K., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70025-7 · Cited by 7,668
Self-citationVerhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575
Self-citationAn Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 2×
“Meanwhile, reduction of hyperpermeability of brain tumor microvessels by anti-VEGF-A treatment may have a rapid positive effect on edematous brain swelling, thereby temporarily improving the quality of life [37, 70].”
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Patel, A. P., Tirosh, I., Trombetta, J. J., Shalek, A. K., Gillespie, S. M., Wakimoto, H., Cahill, D. P., Nahed, B. V., Curry, W. T., Martuza, R. L., et al. (2014) · Science · doi:10.1126/science.1254257 · Cited by 5,063
Reynolds, B. A., & Weiss, S. (1992) · Science · doi:10.1126/science.1553558 · Cited by 4,482
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,007
Self-citationComprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
The Cancer Genome Atlas Research Network (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1402121 · Cited by 3,148
Fundamentals of Cancer Metabolism
DeBerardinis, R. J., & Chandel, N. S. (2016) · Science Advances · doi:10.1126/sciadv.1600200 · Cited by 3,013 · cited 1×
“Another important reason to study glioma in the orthotopic setting relates to tumor cell metabolism [42].”
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Gilbert, M. R., Dignam, J. J., Armstrong, T. S., Wefel, J. S., Blumenthal, D. T., Vogelbaum, M. A., Colman, H., Chakravarti, A., Pugh, S., Won, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1308573 · Cited by 2,834
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
Chinot, O. L., Wick, W., Mason, W., Henriksson, R., Saran, F., Nishikawa, R., Carpentier, A. F., Hoang-Xuan, K., Kavan, P., Cernea, D., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1308345 · Cited by 2,557
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Noushmehr, H., Weisenberger, D. J., Diefes, K., Phillips, H. S., Pujara, K., Berman, B. P., Pan, F., Pelloski, C. E., Sulman, E. P., Bhat, K. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.017 · Cited by 2,337
Self-citationBrewer, G. J., Torricelli, J. R., Evege, E. K., & Price, P. J. (1993) · Journal of Neuroscience Research · doi:10.1002/jnr.490350513 · Cited by 2,325
Lee, J., Kotliarova, S., Kotliarov, Y., Li, A., Su, Q., Donin, N. M., Pastorino, S., Purow, B. W., Christopher, N., Zhang, W., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.030 · Cited by 2,311
Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
Holash, J., Maisonpierre, P. C., Compton, D., Boland, P., Alexander, C. R., Zagzag, D., Yancopoulos, G. D., & Wiegand, S. J. (1999) · Science · doi:10.1126/science.284.5422.1994 · Cited by 2,195
Ceccarelli, M., Barthel, F. P., Malta, T. M., Sabedot, T. S., Salama, S. R., Murray, B. A., Morozova, O., Newton, Y., Radenbaugh, A., Pagnotta, S. M., et al. (2016) · Cell · doi:10.1016/j.cell.2015.12.028 · Cited by 2,189
Self-citationFrom Krebs to clinic: glutamine metabolism to cancer therapy
Altman, B. J., Stine, Z. E., & Dang, C. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.71 · Cited by 2,119
Glioma Groups Based on 1p/19q,IDH, and TERT Promoter Mutations in Tumors
Eckel-Passow, J. E., Lachance, D. H., Molinaro, A. M., Walsh, K. M., Decker, P. A., Sicotte, H., Pekmezci, M., Rice, T., Kosel, M. L., Smirnov, I. V., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1407279 · Cited by 1,982
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
Sottoriva, A., Spiteri, I., Piccirillo, S. G. M., Touloumis, A., Collins, V. P., Marioni, J. C., Curtis, C., Watts, C., & Tavaré, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219747110 · Cited by 1,737
DeAngelis, L. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101113440207 · Cited by 1,663
Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma
Johnson, B. E., Mazor, T., Hong, C., Barnes, M., Aihara, K., McLean, C. Y., Fouse, S. D., Yamamoto, S., Ueda, H., Tatsuno, K., et al. (2014) · Science · doi:10.1126/science.1239947 · Cited by 1,362
Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma
Tirosh, I., Venteicher, A. S., Hebert, C., Escalante, L. E., Patel, A. P., Yizhak, K., Fisher, J. M., Rodman, C., Mount, C., Filbin, M. G., et al. (2016) · Nature · doi:10.1038/nature20123 · Cited by 1,234
Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis
Cully, M., You, H., Levine, A. J., & Mak, T. W. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1819 · Cited by 1,233
Pajtler, K. W., Witt, H., Sill, M., Jones, D. T. W., Hovestadt, V., Kratochwil, F., Wani, K., Tatevossian, R., Punchihewa, C., Johann, P., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.04.002 · Cited by 1,225
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells
Rohle, D., Popovici-Muller, J., Palaskas, N., Turcan, S., Grommes, C., Campos, C., Tsoi, J., Clark, O., Oldrini, B., Komisopoulou, E., et al. (2013) · Science · doi:10.1126/science.1236062 · Cited by 1,153
Brain tumour cells interconnect to a functional and resistant network
Osswald, M., Jung, E., Sahm, F., Solecki, G., Venkataramani, V., Blaes, J., Weil, S., Horstmann, H., Wiestler, B., Syed, M., et al. (2015) · Nature · doi:10.1038/nature16071 · Cited by 1,143
The Definition of Primary and Secondary Glioblastoma
Ohgaki, H., & Kleihues, P. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3002 · Cited by 1,132
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
van Tellingen, O., Yetkin-Arik, B., de Gooijer, M. C., Wesseling, P., Wurdinger, T., & de Vries, H. E. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.02.002 · Cited by 1,035
Self-citationNiche-Independent Symmetrical Self-Renewal of a Mammalian Tissue Stem Cell
Conti, L., Pollard, S. M., Gorba, T., Reitano, E., Toselli, M., Biella, G., Sun, Y., Sanzone, S., Ying, Q.-L., Cattaneo, E., et al. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030283 · Cited by 870
LONG TERM CULTURE OF NORMAL AND NEOPLASTIC HUMAN GLIA
PONTÉN, J., & MACINTYRE, E. H. (1968) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/j.1699-0463.1968.tb03502.x · Cited by 720
Mosaic Amplification of Multiple Receptor Tyrosine Kinase Genes in Glioblastoma
Snuderl, M., Fazlollahi, L., Le, L. P., Nitta, M., Zhelyazkova, B. H., Davidson, C. J., Akhavanfard, S., Cahill, D. P., Aldape, K. D., Betensky, R. A., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.11.005 · Cited by 707
SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma
Son, M. J., Woolard, K., Nam, D.-H., Lee, J., & Fine, H. A. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.03.003 · Cited by 672
Diffuse glioma growth: a guerilla war
Claes, A., Idema, A. J., & Wesseling, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0293-7 · Cited by 636
Self-citationLam, S. H., Chua, H. L., Gong, Z., Lam, T. J., & Sin, Y. M. (2004) · Developmental & Comparative Immunology · doi:10.1016/s0145-305x(03)00103-4 · Cited by 604
Louis, D. N., Perry, A., Burger, P., Ellison, D. W., Reifenberger, G., von Deimling, A., Aldape, K., Brat, D., Collins, V. P., Eberhart, C., et al. (2014) · Brain Pathology · doi:10.1111/bpa.12171 · Cited by 580
Self-citationSpecific-locus test shows ethylnitrosourea to be the most potent mutagen in the mouse.
Russell, W. L., Kelly, E. M., Hunsicker, P. R., Bangham, J. W., Maddux, S. C., & Phipps, E. L. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.11.5818 · Cited by 517
de Groot, J. F., Fuller, G., Kumar, A. J., Piao, Y., Eterovic, K., Ji, Y., & Conrad, C. A. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop027 · Cited by 509
BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1
Tönjes, M., Barbus, S., Park, Y. J., Wang, W., Schlotter, M., Lindroth, A. M., Pleier, S. V., Bai, A. H. C., Karra, D., Piro, R. M., et al. (2013) · Nature Medicine · doi:10.1038/nm.3217 · Cited by 486
Hatanpaa, K. J., Burma, S., Zhao, D., & Habib, A. A. (2010) · Neoplasia · doi:10.1593/neo.10688 · Cited by 471
Origin of the U87MG glioma cell line: Good news and bad news
Allen, M., Bjerke, M., Edlund, H., Nelander, S., & Westermark, B. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6853 · Cited by 466
Oncogenic Isocitrate Dehydrogenase Mutations: Mechanisms, Models, and Clinical Opportunities
Cairns, R. A., & Mak, T. W. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0083 · Cited by 452
Pilocytic astrocytoma: pathology, molecular mechanisms and markers
Collins, V. P., Jones, D. T. W., & Giannini, C. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1410-7 · Cited by 445
Barth, R. F., & Kaur, B. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9875-7 · Cited by 427
Kim, H., Zheng, S., Amini, S. S., Virk, S. M., Mikkelsen, T., Brat, D. J., Grimsby, J., Sougnez, C., Muller, F., Hu, J., et al. (2015) · Genome Research · doi:10.1101/gr.180612.114 · Cited by 411
Self-citationPseudoprogression and pseudoresponse in the treatment of gliomas
Brandsma, D., & van den Bent, M. J. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328332363e · Cited by 378
Cross-species genomics matches driver mutations and cell compartments to model ependymoma
Johnson, R. A., Wright, K. D., Poppleton, H., Mohankumar, K. M., Finkelstein, D., Pounds, S. B., Rand, V., Leary, S. E. S., White, E., Eden, C., et al. (2010) · Nature · doi:10.1038/nature09173 · Cited by 367
Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy
Szatmári, T., Lumniczky, K., Désaknai, S., Trajcevski, S., Hídvégi, E. J., Hamada, H., & Sáfrány, G. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00208.x · Cited by 361
Breedveld, P., Pluim, D., Cipriani, G., Wielinga, P., van Tellingen, O., Schinkel, A. H., & Schellens, J. H. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2416 · Cited by 351
Mouse models in oncoimmunology
Zitvogel, L., Pitt, J. M., Daillère, R., Smyth, M. J., & Kroemer, G. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.91 · Cited by 343
Stereotactic modulation of blood-brain barrier permeability to enhance drug delivery
Appelboom, G., Detappe, A., LoPresti, M., Kunjachan, S., Mitrasinovic, S., Goldman, S., Chang, S. D., & Tillement, O. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now137 · Cited by 340
U87MG Decoded: The Genomic Sequence of a Cytogenetically Aberrant Human Cancer Cell Line
Clark, M. J., Homer, N., O'Connor, B. D., Chen, Z., Eskin, A., Lee, H., Merriman, B., & Nelson, S. F. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000832 · Cited by 310
In vivo models of primary brain tumors: pitfalls and perspectives
Huszthy, P. C., Daphu, I., Niclou, S. P., Stieber, D., Nigro, J. M., Sakariassen, P. O., Miletic, H., Thorsen, F., & Bjerkvig, R. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos135 · Cited by 282
Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art
Karim, R., Palazzo, C., Evrard, B., & Piel, G. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.02.026 · Cited by 252
Narayana, A., Kelly, P., Golfinos, J., Parker, E., Johnson, G., Knopp, E., Zagzag, D., Fischer, I., Raza, S., Medabalmi, P., et al. (2009) · Journal of Neurosurgery · doi:10.3171/2008.4.17492 · Cited by 243
Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs
Roskoski, R. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.03.012 · Cited by 237
Humanized Mouse Xenograft Models: Narrowing the Tumor–Microenvironment Gap
Morton, J. J., Bird, G., Refaeli, Y., & Jimeno, A. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1260 · Cited by 237
Novel Oncogenic PDGFRA Mutations in Pediatric High-Grade Gliomas
Paugh, B. S., Zhu, X., Qu, C., Endersby, R., Diaz, A. K., Zhang, J., Bax, D. A., Carvalho, D., Reis, R. M., Onar-Thomas, A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1491 · Cited by 235
Current Review of in Vivo GBM Rodent Models: Emphasis on the CNS-1 Tumour Model
Jacobs, V. L., Valdes, P. A., Hickey, W. F., & De Leo, J. A. (2011) · ASN Neuro · doi:10.1042/an20110014 · Cited by 234
Leenders, W. P. J., Küsters, B., Verrijp, K., Maass, C., Wesseling, P., Heerschap, A., Ruiter, D., Ryan, A., & de Waal, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0823 · Cited by 231
Self-citationA novel transgenic zebrafish model for blood-brain and blood-retinal barrier development
Xie, J., Farage, E., Sugimoto, M., & Anand-Apte, B. (2010) · BMC Developmental Biology · doi:10.1186/1471-213x-10-76 · Cited by 228
Oligodendroglioma: pathology, molecular mechanisms and markers
Wesseling, P., van den Bent, M., & Perry, A. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1424-1 · Cited by 226
Self-citationStudies on the chemotherapy of experimental brain tumors: development of an experimental model.
Ausman, J. I., Shapiro, W. R., & Rall, D. P. (1970) · PubMed · Cited by 223
PTEN regulatory functions in tumor suppression and cell biology.
Chu, E. C., & Tarnawski, A. S. (2004) · PubMed · Cited by 221
A Drosophila Model for EGFR-Ras and PI3K-Dependent Human Glioma
Read, R. D., Cavenee, W. K., Furnari, F. B., & Thomas, J. B. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000374 · Cited by 209
Invasive Glioblastoma Cells Acquire Stemness and Increased Akt Activation
Molina, J. R., Hayashi, Y., Stephens, C., & Georgescu, M.-M. (2010) · Neoplasia · doi:10.1593/neo.10126 · Cited by 200
An in vivo patient-derived model of endogenous IDH1-mutant glioma
Luchman, H. A., Stechishin, O. D., Dang, N. H., Blough, M. D., Chesnelong, C., Kelly, J. J., Nguyen, S. A., Chan, J. A., Weljie, A. M., Cairncross, J. G., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nor207 · Cited by 198
DETERMINANTS FOR THE ESTABLISHMENT OF PERMANENT TISSUE CULTURE LINES FROM HUMAN GLIOMAS
Westermark, B., Pontén, J., & Hugosson, R. (1973) · Acta Pathologica Microbiologica Scandinavica Section A Pathology · doi:10.1111/j.1699-0463.1973.tb03573.x · Cited by 193
Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme
Verhoeff, J. J., van Tellingen, O., Claes, A., Stalpers, L. J., van Linde, M. E., Richel, D. J., Leenders, W. P., & van Furth, W. R. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-444 · Cited by 189
Self-citationCen, L., Carlson, B. L., Schroeder, M. A., Ostrem, J. L., Kitange, G. J., Mladek, A. C., Fink, S. R., Decker, P. A., Wu, W., Kim, J.-S., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos114 · Cited by 189
CHU, C. T., EVERISS, K. D., WIKSTRAND, C. J., BATRA, S. K., KUNG, H.-J., & BIGNER, D. D. (1997) · Biochemical Journal · doi:10.1042/bj3240855 · Cited by 184
Torsvik, A., Stieber, D., Enger, P. Ø., Golebiewska, A., Molven, A., Svendsen, A., Westermark, B., Niclou, S. P., Olsen, T. K., Chekenya Enger, M., et al. (2014) · Cancer Medicine · doi:10.1002/cam4.219 · Cited by 179
Tumor treating fields: A novel treatment modality and its use in brain tumors
Hottinger, A. F., Pacheco, P., & Stupp, R. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now182 · Cited by 177
A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylation
Duncan, C. G., Barwick, B. G., Jin, G., Rago, C., Kapoor-Vazirani, P., Powell, D. R., Chi, J.-T., Bigner, D. D., Vertino, P. M., & Yan, H. (2012) · Genome Research · doi:10.1101/gr.132738.111 · Cited by 176
Bardella, C., Al‐Dalahmah, O., Krell, D., Brazauskas, P., Al‐Qahtani, K., Tomková, M., Adam, J., Serres, S., Lockstone, H. E., Freeman-Mills, L., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.08.017 · Cited by 172
Ernst, A., Hofmann, S., Ahmadi, R., Becker, N., Korshunov, A., Engel, F., Hartmann, C., Felsberg, J., Sabel, M., Peterziel, H., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0695 · Cited by 171
Amplification of KIT, PDGFRA, VEGFR2, and EGFR in Gliomas
Puputti, M., Tynninen, O., Sihto, H., Blom, T., Mäenpää, H., Isola, J., Paetau, A., Joensuu, H., & Nupponen, N. N. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0085 · Cited by 171
Talasila, K. M., Soentgerath, A., Euskirchen, P., Røsland, G. V., Wang, J., Huszthy, P. C., Prestegarden, L., Skaftnesmo, K. O., Sakariassen, P. Ø., Eskilsson, E., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1101-1 · Cited by 170
The role of DNA damage responses in p53 biology
Speidel, D. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1459-z · Cited by 160
de Vries, N. A., Buckle, T., Zhao, J., Beijnen, J. H., Schellens, J. H. M., & van Tellingen, O. (2012) · Investigational New Drugs · doi:10.1007/s10637-010-9569-1 · Cited by 158
Vessel Co-Option: How Tumors Obtain Blood Supply in the Absence of Sprouting Angiogenesis
Leenders, W. P. J., Küsters, B., & de Waal, R. M. W. (2002) · Endothelium · doi:10.1080/10623320212006 · Cited by 150
Self-citationABCB1, ABCG2, and PTEN Determine the Response of Glioblastoma to Temozolomide and ABT-888 Therapy
Lin, F., de Gooijer, M. C., Roig, E. M., Buil, L. C. M., Christner, S. M., Beumer, J. H., Würdinger, T., Beijnen, J. H., & van Tellingen, O. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0084 · Cited by 145
Bevacizumab for Newly Diagnosed Glioblastoma
Gilbert, M. R., Sulman, E. P., & Mehta, M. P. (2014) · New England Journal of Medicine · doi:10.1056/nejmc1403303 · Cited by 142
VEGF Trap in Combination With Radiotherapy Improves Tumor Control in U87 Glioblastoma
Wachsberger, P. R., Burd, R., Cardi, C., Thakur, M. L., Daskalakis, C., Holash, J. A., Yancopoulos, G. D., & Dicker, A. P. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.11.011 · Cited by 139
Reproducibility: changing the policies and culture of cell line authentication
Freedman, L. P., Gibson, M. C., Ethier, S. P., Soule, H. R., Neve, R. M., & Reid, Y. A. (2015) · Nature Methods · doi:10.1038/nmeth.3403 · Cited by 136
Patru, C., Romão, L. F., Varlet, P., Coulombel, L., Raponi, É., Cadusseau, J., Renault-Mihara, F., Thirant, C., Léonard, N., Berhneim, A., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-66 · Cited by 132
Glutamate transporters in the biology of malignant gliomas
Robert, S. M., & Sontheimer, H. W. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1521-z · Cited by 130
Yang, P., Cai, J., Yan, W., Zhang, W., Wang, Y., Chen, B., Li, G., Li, S., Wu, C., Yao, K., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now021 · Cited by 127
Stieber, D., Golebiewska, A., Evers, L., Lenkiewicz, E., Brons, N. H. C., Nicot, N., Oudin, A., Bougnaud, S., Hertel, F., Bjerkvig, R., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1196-4 · Cited by 118
Gielen, P. R., Schulte, B. M., Kers‐Rebel, E. D., Verrijp, K. C. N., Petersen-Baltussen, H. M. J. M., ter Laan, M., Wesseling, P., & Adema, G. J. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000183 · Cited by 117
Self-citationGlioma cells showing IDH1 mutation cannot be propagated in standard cell culture conditions
Piaskowski, S., Bieńkowski, M., Stoczyńska-Fidelus, E., Stawski, R. S., Sieruta, M., Szybka, M., Papierz, W., Wolańczyk, M., Jaskólski, D. J., Liberski, P. P., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.27 · Cited by 113
Peptide‐Mediated Blood–Brain Barrier Transport of Polymersomes
Georgieva, J. V., Brinkhuis, R. P., Stojanov, K., Weijers, C. A. G. M., Zuilhof, H. T., Rutjes, F. P. J. T., Hoekstra, D., van Hest, J. C. M., & Zuhorn, I. S. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201202001 · Cited by 113
Genetic modeling of gliomas in mice: New tools to tackle old problems
Hambardzumyan, D., Parada, L. F., Holland, E. C., & Charest, A. (2011) · Glia · doi:10.1002/glia.21142 · Cited by 109
Host Microvasculature Influence on Tumor Vascular Morphology and Endothelial Gene Expression
Roberts, W. G., Delaat, J. L., Nagane, M., Huang, S., Cavenee, W. K., & Palade, G. E. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65668-4 · Cited by 108
Unravelling tumour heterogeneity—implications for therapy
Reardon, D. A., & Wen, P. Y. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.223 · Cited by 106
Erratum: From Krebs to clinic: glutamine metabolism to cancer therapy
Altman, B. J., Stine, Z. E., & Dang, C. V. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.131 · Cited by 101
Molecular Subtypes of Glioblastoma Are Relevant to Lower Grade Glioma
Guan, X., Vengoechea, J. E., Zheng, S., Sloan, A. E., Chen, Y., Brat, D. J., O’Neill, B. P., de Groot, J., Yust‐Katz, S., Yung, W.-K. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091216 · Cited by 100
Self-citationGlioblastoma cancer stem cells – From concept to clinical application
Stopschinski, B. E., Beier, C. P., & Beier, D. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.05.033 · Cited by 96
Safety Validation of Repeated Blood–Brain Barrier Disruption Using Focused Ultrasound
Kobus, T., Vykhodtseva, N. I., Pilatou, M. C., Zhang, Y., & McDannold, N. J. (2015) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2015.10.009 · Cited by 96
LeBlanc, A. K., Mazcko, C. N., Brown, D. E., Koehler, J. W., Miller, A. D., Miller, C. R., Bentley, R. T., Packer, R. A., Breen, M., Boudreau, C. E., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now051 · Cited by 94
Grauer, O. M., Sutmuller, R. P. M., van Maren, W. W. C., Jacobs, J. F. M., Bennink, E. J., Toonen, L. W. J., Nierkens, S., & Adema, G. J. (2007) · International Journal of Cancer · doi:10.1002/ijc.23284 · Cited by 92
Lin, F., de Gooijer, M. C., Hanekamp, D., Chandrasekaran, G., Buil, L. C. M., Thota, N., Sparidans, R. W., Beijnen, J. H., Würdinger, T., & van Tellingen, O. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1276 · Cited by 90
de Gooijer, M. C., Zhang, P., Thota, N., Mayayo‐Peralta, I., Buil, L. C. M., Beijnen, J. H., & van Tellingen, O. (2015) · Investigational New Drugs · doi:10.1007/s10637-015-0266-y · Cited by 88
Focused ultrasound-aided immunomodulation in glioblastoma multiforme: a therapeutic concept
Cohen‐Inbar, O., Xu, Z., & Sheehan, J. P. (2016) · Journal of Therapeutic Ultrasound · doi:10.1186/s40349-016-0046-y · Cited by 83
Establishment of human iPSC-based models for the study and targeting of glioma initiating cells
Sancho-Martinez, I., Nivet, E., Xia, Y. F., Hishida, T., Aguirre, A., Ocampo, A., Ma, L., Morey, R. E., Krause, M. N., Zembrzycki, A., et al. (2016) · Nature Communications · doi:10.1038/ncomms10743 · Cited by 83
Characterizing and targeting PDGFRA alterations in pediatric high-grade glioma
Koschmann, C. J., Zamler, D. B., Mackay, A. G., Robinson, D. R., Wu, Y.-M., Doherty, R. E., Marini, B. L., Tran, D., Garton, H. J. L., Muraszko, K. M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11602 · Cited by 83
Malzkorn, B., & Reifenberger, G. (2016) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000327 · Cited by 79
Modeling Glioma Growth and Invasion in Drosophila melanogaster
Witte, H. T., Jeibmann, A., Klämbt, C., & Paulus, W. (2009) · Neoplasia · doi:10.1593/neo.09576 · Cited by 76
An activated mutant BRAF kinase domain is sufficient to induce pilocytic astrocytoma in mice
Gronych, J., Korshunov, A., Bageritz, J., Milde, T., Jugold, M., Hambardzumyan, D., Remke, M., Hartmann, C. J., Witt, H., Jones, D., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44656 · Cited by 75
Navis, A. C., Bourgonje, A. M., Wesseling, P., Wright, A. J., Hendriks, W. J. A. J., Verrijp, K. C. N., van der Laak, J. A. W. M., Heerschap, A., & Leenders, W. P. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058262 · Cited by 75
Self-citationEmerging Applications of Therapeutic Ultrasound in Neuro-oncology: Moving Beyond Tumor Ablation
Hersh, D. S., Kim, A. J., Winkles, J. A., Eisenberg, H. M., Woodworth, G. F., & Frenkel, V. (2016) · Neurosurgery · doi:10.1227/neu.0000000000001399 · Cited by 74
Claes, A., Schuuring, J., Boots‐Sprenger, S., Hendriks-Cornelissen, S. J. B., Dekkers, M. M. G., van der Kogel, A. J., Leenders, W. P. J., Wesseling, P., & Jeuken, J. W. M. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00141.x · Cited by 72
Self-citationBalvers, R. K., Kleijn, A., Kloezeman, J. J., French, P. J., Kremer, A., van den Bent, M. J., Dirven, C. M. F., Leenstra, S., & Lamfers, M. L. M. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not116 · Cited by 70
Bota, D. A., Alexandru, D., Keir, S. T., Bigner, D. D., Vredenburgh, J. J., & Friedman, H. S. (2013) · Journal of neurosurgery · doi:10.3171/2013.7.jns1323 · Cited by 68
A Mouse Model for Glioma: Biology, Pathology, and Therapeutic Opportunities
Holland, E. C. (2000) · Toxicologic Pathology · doi:10.1177/019262330002800122 · Cited by 68
Molecular pathology of paediatric central nervous system tumours
Chiang, J., & Ellison, D. W. (2016) · The Journal of Pathology · doi:10.1002/path.4813 · Cited by 66
Navis, A. C., Niclou, S. P., Fack, F., Stieber, D., van Lith, S. A. M., Verrijp, K. N., Wright, A. J., Stauber, J., Tops, B. B. J., Otte‐Höller, I., et al. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-18 · Cited by 64
Self-citationDiffusely infiltrating astrocytomas: pathology, molecular mechanisms and markers
Ichimura, K., Narita, Y., & Hawkins, C. E. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1439-7 · Cited by 62
Caretti, V., Zondervan, I., Meijer, D. H., Idema, S., Vos, W., Hamans, B. C., Bugiani, M., Hulleman, E., Wesseling, P., Vandertop, W. P., et al. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00468.x · Cited by 61
Self-citationYang, W., Barth, R. F., Wu, G. J., Ciesielski, M. J., Fenstermaker, R. A., Moffat, B. A., Ross, B. D., & Wikstrand, C. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.341.11.1 · Cited by 61
Tumor Gene Therapy Made Easy: Allogeneic Major Histocompatibility Complex in the C6 Rat Glioma Model
Beutler, A. S., Banck, M. S., Wedekind, D., & Hedrich, H. J. (1999) · Human Gene Therapy · doi:10.1089/10430349950019228 · Cited by 59
Characterisation of tumour vasculature in mouse brain by USPIO contrast-enhanced MRI
Gambarota, G., Leenders, W. P. J., Maass, C., Wesseling, P., van der Kogel, B., van Tellingen, O., & Heerschap, A. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604389 · Cited by 59
Self-citationOrthotopic models of pediatric brain tumors in zebrafish
Eden, C., Ju, B. H., Murugesan, M., Phoenix, T. N., Nimmervoll, B. V., Tong, Y., Ellison, D. W., Finkelstein, D., Wright, K. D., Boulos, N., et al. (2014) · Oncogene · doi:10.1038/onc.2014.107 · Cited by 58
Welker, A. M., Jaros, B. D., Puduvalli, V. K., Imitola, J., Kaur, B., & Beattie, C. E. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.022921 · Cited by 53
Expanding the spectrum of IDH1 mutations in gliomas
Gupta, R., Flanagan, S., Li, C. C. Y., Lee, M. C., Shivalingham, B., Maleki, S., Wheeler, H., & Buckland, M. E. (2013) · Modern Pathology · doi:10.1038/modpathol.2012.210 · Cited by 52
Glutamate as chemotactic fuel for diffuse glioma cells: Are they glutamate suckers?
van Lith, S. A. M., Navis, A. C., Verrijp, K. N., Niclou, S. P., Bjerkvig, R., Wesseling, P., Tops, B. B. J., Molenaar, R. J., Noorden, C. J. F. V., & Leenders, W. P. J. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.04.004 · Cited by 52
Self-citationTortorella, S., & Karagiannis, T. (2014) · Current Drug Delivery · doi:10.2174/1567201810666140106115436 · Cited by 51 · cited 1×
“Numerous research efforts to get drugs over the BBB are ongoing, including active transport of peptide- or antibody-coated nanoparticles [50, 73, 145].”
Rapid and Robust Transgenic High-Grade Glioma Mouse Models for Therapy Intervention Studies
de Vries, N. A., Bruggeman, S. W. M., Hulsman, D., de Vries, H. I., Zevenhoven, J., Buckle, T., Hamans, B. C., Leenders, W. P. J., Beijnen, J. H., van Lohuizen, M., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3414 · Cited by 50
Self-citationProminin-1 (CD133) Defines Both Stem and Non-Stem Cell Populations in CNS Development and Gliomas
Olausson, K. H., Maire, C. L., Haidar, S., Ling, J., Learner, E. R., Nistér, M., & Ligon, K. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106694 · Cited by 49
Klink, B., Miletić, H., Stieber, D., Huszthy, P. C., Valenzuela, J. A. C., Balß, J., Wang, J., Schubert, M., Sakariassen, P. Ø., Sundstrøm, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059773 · Cited by 46
Navis, A. C., van Lith, S. A. M., van Duijnhoven, S. M. J., de Pooter, M., Yetkin-Arik, B., Wesseling, P., Hendriks, W. J. A. J., Venselaar, H., Timmer, M., van Cleef, P., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1420-5 · Cited by 45
Self-citationMurine cell line model of proneural glioma for evaluation of anti-tumor therapies
Sonabend, A. M., Yun, J. J., Lei, L., Leung, R., Soderquist, C. R., Crisman, C., Gill, B. J. A., Carminucci, A. S., Sisti, J. S., Castelli, M., et al. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1082-x · Cited by 44
Kim, Y.-W., Liu, T. J., Koul, D., Tiao, N., Feroze, A. H., Wang, J., Powis, G., & Yung, W. K. A. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor012 · Cited by 43
Bier, E., & Reiter, L. T. (2002) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.6.3.387 · Cited by 43
The Study of Glioma by Xenotransplantation in Zebrafish Early Life Stages
Vittori, M., Motaln, H., & Turnšek, T. L. (2015) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155415595670 · Cited by 42
Future perspectives in cancer immunotherapy
Tsiatas, M. L., Mountzios, G., & Curigliano, G. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.07.14 · Cited by 40
Vitanza, N. A., & Partap, S. (2015) · Journal of Child Neurology · doi:10.1177/0883073815610428 · Cited by 40
Humanized Mice to Study FcγR Function
Bournazos, S., DiLillo, D. J., & Ravetch, J. V. (2014) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-07911-0_11 · Cited by 39
Bourgonje, A. M., Navis, A. C., Schepens, J. T. G., Verrijp, K. N., Hovestad-Bijl, L., Hilhorst, R., Harroch, S., Wesseling, P., Leenders, W. P. J., & Hendriks, W. J. A. J. (2014) · Oncotarget · doi:10.18632/oncotarget.2366 · Cited by 39
Self-citationvan Lith, S. A. M., Molenaar, R. J., Noorden, C. J. F. V., & Leenders, W. P. J. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou152 · Cited by 35
Self-citationPenne, K., Bohlin, C., Schneider, S. M., & Allen, D. E. (2005) · Cancer Nursing · doi:10.1097/00002820-200511000-00012 · Cited by 35
Tight Junctions of the Blood-Brain Barrier - A Molecular Gatekeeper
Bauer, H., & Traweger, A. (2016) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666160915142244 · Cited by 35
Lin, F., Buil, L. C. M., Sherris, D., Beijnen, J. H., & van Tellingen, O. (2013) · International Journal of Cancer · doi:10.1002/ijc.28126 · Cited by 34
Chung, C. D., Jalali, S., Foltz, W. D., Burrell, K. E., Wildgoose, P., Lindsay, P. E., Graves, C. A., Camphausen, K. A., Milosevic, M., Jaffray, D. A., et al. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.07.005 · Cited by 33
Pharmaceutical Targeting of the Brain
Krizbai, I. A., Nyúl‐Tóth, Á., Bauer, H., Farkas, A. E., Traweger, A., Haskó, J., Bauer, H., & Wilhelm, I. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160726144203 · Cited by 33
Tumour control by whole brain irradiation of anti-VEGF-treated mice bearing intracerebral glioma
Verhoeff, J. J. C., Stalpers, L. J. A., Claes, A., Hovinga, K. E., Musters, G. D., Vandertop, W. P., Richel, D. J., Leenders, W. P. J., & van Furth, W. R. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.08.004 · Cited by 32
Self-citationRoodink, I., van der Laak, J. A. W. M., Küsters, B., Wesseling, P., Verrijp, K. C. N., de Waal, R., & Leenders, W. P. J. (2006) · International Journal of Cancer · doi:10.1002/ijc.22072 · Cited by 31
Self-citationBriançon‐Marjollet, A., Balenci, L., Fernandez, M., Estève, F., Honnorat, J., Farion, R., Beaumont, M., Barbier, E., Rémy, C., & Baudier, J. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq154 · Cited by 28
Hamans, B. C., Navis, A. C., Wright, A. J., Wesseling, P., Heerschap, A., & Leenders, W. P. J. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not129 · Cited by 28
Self-citationEffects of targeting the VEGF and PDGF pathways in diffuse orthotopic glioma models
Navis, A. C., Hamans, B. C., Claes, A., Heerschap, A., Jeuken, J. W. M., Wesseling, P., & Leenders, W. P. J. (2010) · The Journal of Pathology · doi:10.1002/path.2836 · Cited by 27
Self-citationSundlisæter, E., Wang, J., Sakariassen, P. Ø., Marie, M., Mathisen, J. R., Karlsen, B. O., Prestegarden, L., Skaftnesmo, K. O., Bjerkvig, R., & Enger, P. Ø. (2006) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00744.x · Cited by 26
Ependymoma stem cells are highly sensitive to temozolomide in vitro and in orthotopic models
Meco, D., Servidei, T., Lamorte, G., Binda, E., Arena, V., & Riccardi, R. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou008 · Cited by 26
Animal models to study cancer-initiating cells from Glioblastoma
Wee, B. (2011) · Frontiers in bioscience · doi:10.2741/3851 · Cited by 21
BCAT1 defines gliomas by IDH status
Mayers, J. R., & Heiden, M. G. V. (2013) · Nature Medicine · doi:10.1038/nm.3263 · Cited by 20
Role of isocitrate dehydrogenase in glioma
Alexander, B. M., & Mehta, M. P. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.134 · Cited by 18
Ettl, J. (2016) · Breast Care · doi:10.1159/000447417 · Cited by 15
Potter, N. E., Phipps, K. P., Harkness, W. F. J., Hayward, R. D., Thompson, D. N. P., Jacques, T. S., Harding, B. N., Thomas, D. G. T., Rees, J. H., Darling, J. L., et al. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.06.003 · Cited by 14
Sprouting angiogenesis versus co-option in tumor angiogenesis
de Waal, R. M. W., & Leenders, W. P. J. (2005) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7311-3_5 · Cited by 12
Self-citationWang, Q., Satomi, K., Oh, J. E., Hutter, B., Brors, B., Diessl, N., Liu, H., Wolf, S., Wiestler, O. D., Kleihues, P., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.05.024 · Cited by 12
In situ dendritic cell vaccination for the treatment of glioma and literature review
Li, M., Han, S., & Shi, X. (2015) · Tumor Biology · doi:10.1007/s13277-015-3958-1 · Cited by 6
Transcriptomic Analyses in Zebrafish Cancer Models for Global Gene Expression and Pathway Discovery
Huang, X., Agrawal, I., Li, Z., Zheng, W., Lin, Q., & Gong, Z. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-30654-4_7 · Cited by 3
Cited by
Emerging therapies for glioblastoma: current state and future directions
Rong, L., Li, N., & Zhang, Z. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02349-7 · Cited by 510
Salunkhe, S., Dheeraj, Basak, M., Chitkara, D., & Mittal, A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.042 · Cited by 497
Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression
Yee, P. P., Wei, Y., Kim, S.-Y., Lu, T., Chih, S. Y., Lawson, C., Tang, M., Liu, Z., Anderson, B., Thamburaj, K., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19193-y · Cited by 412
Tumor microenvironment in glioblastoma: Current and emerging concepts
Sharma, P., Aaroe, A., Liang, J., & Puduvalli, V. K. (2023) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdad009 · Cited by 314
Vaubel, R. A., Tian, S., Remonde, D., Schroeder, M. A., Mladek, A. C., Kitange, G. J., Caron, A., Kollmeyer, T. M., Grove, R., Peng, S., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0909 · Cited by 227
Self-citation
Metadata
- Authors
- Lenting, K., Verhaak, R., ter Laan, M., Wesseling, P., & Leenders, W.
- Venue
- Acta Neuropathologica
- Published
- 2017-01-10
- Volume
- 133
- Issue
- 2
- Pages
- 263-282
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2570696586
- Cited by
- 287
- References
- 164
- FWCI
- 16.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.